Literature DB >> 26598718

Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.

Hong Hong1, Wenbin Xiao1, Hillard M Lazarus1, Caryn E Good1, Robert W Maitta1, Michael R Jacobs1.   

Abstract

Septic transfusion reactions (STRs) resulting from transfusion of bacterially contaminated platelets are a major hazard of platelet transfusion despite recent interventions. Active and passive surveillance for bacterially contaminated platelets was performed over 7 years (2007-2013) by culture of platelet aliquots at time of transfusion and review of reported transfusion reactions. All platelet units had been cultured 24 hours after collection and released as negative. Five sets of STR criteria were evaluated, including recent AABB criteria; sensitivity and specificity of these criteria, as well as detection by active and passive surveillance, were determined. Twenty of 51,440 platelet units transfused (0.004%; 389 per million) were bacterially contaminated by active surveillance and resulted in 5 STRs occurring 9 to 24 hours posttransfusion; none of these STRs had been reported by passive surveillance. STR occurred only in neutropenic patients transfused with high bacterial loads. A total of 284 transfusion reactions (0.55%) were reported by passive surveillance. None of these patients had received contaminated platelets. However, 6 to 93 (2.1%-32.7%) of these 284 reactions met 1 or more STR criteria, and sensitivity of STR criteria varied from 5.1% to 45.5%. These results document the continued occurrence of bacterial contamination of platelets resulting in STR in neutropenic patients, failure of passive surveillance to detect STR, and lack of specificity of STR criteria. These findings highlight the limitations of reported national STR data based on passive surveillance and the need to implement further measures to address this problem such as secondary testing or use of pathogen reduction technologies.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2015        PMID: 26598718     DOI: 10.1182/blood-2015-07-655944

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions.

Authors:  Seema Kacker; Evan M Bloch; Paul M Ness; Eric A Gehrie; Christi E Marshall; Parvez M Lokhandwala; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-01-08       Impact factor: 3.157

2.  Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology.

Authors:  Dariusz Piotrowski; Zofia Przybylska-Baluta; Teresa Jimenez-Marco; Lina Kryzauskaite; Andreas Papachronis; Aliki Marinaki; Paul Höcker; Sigrid Cherrier-de Wilde; Marcia Cardoso
Journal:  Blood Transfus       Date:  2017-03-23       Impact factor: 3.443

3.  Atypical Bacterial Growth within Units of Platelets Challenges Transfusion Medicine Dogma.

Authors:  Eric A Gehrie
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

Review 4.  Pathogen-reduced platelets for the prevention of bleeding.

Authors:  Lise J Estcourt; Reem Malouf; Sally Hopewell; Marialena Trivella; Carolyn Doree; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2017-07-30

5.  Bacterial contamination of blood products for transfusion in the Democratic Republic of the Congo: temperature monitoring, qualitative and semi-quantitative culture.

Authors:  Anne-Sophie Heroes; Natacha Ndalingosu; Jocelyne Kalema; Aimée Luyindula; Dorothée Kashitu; Catherine Akele; Jeff Kabinda; Katrien Lagrou; Philippe Vandekerckhove; Jan Jacobs; Octavie Lunguya
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

6.  Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.

Authors:  Bruce S Sachais; Sarai Paradiso; Donna Strauss; Beth H Shaz
Journal:  Blood Adv       Date:  2017-06-23

Review 7.  Microbiological Screening of Platelet Concentrates in Europe.

Authors:  Marcel Prax; Isabelle Bekeredjian-Ding; Oleg Krut
Journal:  Transfus Med Hemother       Date:  2019-03-20       Impact factor: 3.747

8.  Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.

Authors:  Americo Cicchetti; Silvia Coretti; Francesco Sacco; Paolo Rebulla; Alessandra Fiore; Filippo Rumi; Rossella Di Bidino; Luz I Urbina; Pietro Refolo; Dario Sacchini; Antonio G Spagnolo; Emanuela Midolo; Giuseppe Marano; Blandina Farina; Ilaria Pati; Eva Veropalumbo; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-09-03       Impact factor: 3.443

9.  Transfusion-Associated Immunomodulation in Critically Ill Patients: More Than Just Red Cells?

Authors:  Jeffrey Wang; Willard N Applefeld; Janhavi Athale
Journal:  Crit Care Med       Date:  2021-06-01       Impact factor: 9.296

10.  Transfusion-associated adverse events and implementation of blood safety measures - findings from the 2017 National Blood Collection and Utilization Survey.

Authors:  Alexandra A Savinkina; Kathryn A Haass; Mathew R P Sapiano; Richard A Henry; James J Berger; Sridhar V Basavaraju; Jefferson M Jones
Journal:  Transfusion       Date:  2020-03       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.